US 8354419
Benzimidazole analogues for the treatment or prevention of flavivirus infections
granted A61PA61P1/16A61P3/00
Quick answer
US patent 8354419 (Benzimidazole analogues for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P1/16, A61P3/00, A61P31/14